The 24th International AIDS Conference (AIDS 2022), 29 July-2 August 2022, Montreal, Canada and virtually

第 24 届国际艾滋病大会 (AIDS 2022)，2022 年 7 月 29 日至 8 月 2 日，加拿大蒙特利尔

• 批准号: 10481133
• 负责人: Christopher C. Beyrer
• 金额: $ 88.5万
• 依托单位: IAS
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-04-19 至 2023-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10481133
• 关键词: 2019-nCoV; AIDS prevention; AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Address; Advocate; Affect; Antiviral Therapy; Area; Attention; Basic Science; Behavioral Research; COVID-19; COVID-19 pandemic; COVID-19 pandemic effects; COVID-19 vaccine; Canada; Caring; Child; Clinical Research; Communities; Consensus; Country; Data; Development; Discipline; Discrimination; Disease Progression; Disease remission; Economics; Environment; Epidemic; Epidemiology; Face; Financial Support; Fostering; Goals; HIV; HIV Infections; HIV vaccine; HIV/TB; Health; Health system; Homophobia; Human Rights; Hybrids; Immunization; Impairment; Incidence; Indigenous; Injectable; International; International AIDS; Intervention; Investments; Knowledge; Laws; Lead; Leadership; Learning; Life Expectancy; Modeling; Monitor; Morbidity - disease rate; Oral; Outcome; Participant; Pathogenesis; Persons; Policies; Politics; Prevention; Prevention approach; Preventive vaccine; Privatization; Research; Research Design; Research Personnel; Resources; Risk; SARS-CoV-2 infection; Science; Science Policy; Scientist; Services; Social Behavior; System; Technology; Telemedicine; Training; Translational Research; Travel; United Nations; Update; Vaccines; Viral hepatitis; Work; Youth; co-infection; community based participatory research; comorbidity; criminal behavior; design; economic determinant; health disparity; illicit drug use; implementation barriers; implementation research; implementation science; innovation; low and middle-income countries; marginalized population; multidisciplinary; neglect; next generation; novel; pandemic disease; pandemic preparedness; patient oriented; person centered; prevent; programs; racial and ethnic disparities; response; same-sex partnership; service delivery; sex; social; social stigma; success; symposium; synergism; transmission process; transphobia; virtual

Project Summary The advances in HIV science across the past 40 years have been remarkable, with near normal life expectancy for persons on antiviral therapy and ever widening access to prevention, treatment and care. However, we do not have an effective HIV vaccine or a cure for the 37 million people living with HIV infection worldwide. The June 2021 United Nations Political Declaration on HIV and AIDS sets new targets and offers welcome clarity on the breadth of policy interventions and resource investments required to meet these objectives. But these will only become a reality if evidence informs policy and scientific innovation continues to provide ever better solutions to remaining biomedical, socio-behavioral and implementation challenges. A global convening bringing together scientists, clinicians, affected community leadership, implementers, donors, and political leaders is thus urgently needed to critically define future research agendas, shift new evidence to action and chart a new consensus on achieving the still elusive goal of pandemic control of HIV. The theme of AIDS 2022, “Re-engage & follow the science” epitomizes this urgency. Recognizing that uneven rollout of COVID-19 vaccines will likely prevent many key stakeholders particularly from countries with a high burden of HIV from travelling internationally, AIDS 2022 will be a fully hybrid conference (29 July-2 August 2022). In addition to the virtual conference platform, Montreal will provide a compelling venue for AIDS 2022 as a leading center of HIV science, with a view to the progressive Canadian policy environment for those at risk and in recognition of Canadian leadership in global cooperation to address the epidemic. Specific aims for AIDS 2022 are to: 1. Accelerate scientific discovery to drive innovation across the HIV prevention and treatment cascades, including pathogenesis, transmission, vaccines, remission and a functional cure; long-acting oral and injectable treatment and prevention technologies, including rings for prevention; integrated and differentiated models of care; and analyses of structural and economic determinants of health. 2. Accelerate updates to treatment guidance especially for low and middle-income countries, infected children and persons with HIV, TB, viral hepatitis and COVID-19 infection. 3. Facilitate the adaptation of innovations from the response to COVID-19 across science, policy and practice and consolidating good practice for pandemic preparedness, and immunization efforts including new partnerships between public and private stakeholders and learnings from adaptations from the HIV response that accelerated the response to COVID-19. 4. Advance core components of implementation science research that address the challenges and opportunities of integration across a range of epidemic settings and in the COVID-19 era, including findings from community-led research, monitoring and innovations in service delivery, including telemedicine. 5. Address HIV vulnerability and determinants of disease progression among key and marginalized populations, including novel interventions and implementation science to reduce stigma and discrimination, including intersectional stigmas of HIV, homophobia, transphobia, and ethnic and racial disparities, including those among indigenous/first nation communities and impact of criminalization of behaviours including same- sex relationships, illicit drug use, and sex work. 6. Draw attention to enduring gaps in the HIV response, such as areas where greater investment is needed in research and person-centered service delivery, and where the needs of communities remain neglected. The scientific program will consist of six tracks: Track A/Basic and Translational Research; Track B/Clinical Research; Track C/Epidemiology and Prevention Science; Track D/Social and Behavioral Research; Track E/ Implementation Research, Economics, Systems and Synergies with other Health and Development Sectors; and Track F/Political research, law, policy and human rights. While the scientific program of the conference is developed by international track committees that represent different disciplines and areas of science, cross- cutting aspects will be covered in plenary talks that also connect the scientific tracks with community and leadership perspectives. Additionally, bridging sessions are designed to cut across at least two of the scientific tracks to provide opportunities for multi-disciplinary, multi-perspective dialogues, often using interactive formats. The participation of young researchers, basic scientists and researchers in related fields such as non- communicable diseases will be strengthened by active solicitation of relevant science and the provision of specific financial support, in addition to remote-access options. Key science from the conference will be disseminated and discussed in regional contexts following AIDS 2022.

项目摘要 在过去40年中，艾滋病毒科学的进步非常出色，预期寿命几乎是正常的 适用于抗病毒疗法的人，并不断扩大预防，治疗和护理的机会。但是，我们这样做 对于全世界感染HIV感染的3700万人，没有有效的HIV疫苗或治疗方法。这 2021年6月，联合国关于艾滋病毒和艾滋病的政治宣言设定了新的目标，并欢迎对 实现这些目标所需的政策干预和资源投资的广度。但是这些会 仅当证据为政策和科学创新提供信息时，才成为现实 保持生物医学，社会行为和实施挑战的解决方案。全球召集带来 因此 迫切需要定义未来的研究议程，将新的证据转移到行动并绘制新的新证据，并将 关于实现艾滋病毒大流行控制仍然难以捉摸的目标的共识。艾滋病的主题2022，“重新参与 并遵循科学”表明这一紧迫感。 认识到COVID-19疫苗的不均匀推出可能会阻止许多关键利益相关者，尤其是 艾滋病2022年，国际旅行的艾滋病毒燃烧高度燃烧的国家将是一次完全混合的会议 （2022年7月29日）。除虚拟会议平台外，蒙特利尔还将提供引人入胜的场地 对于2022年的艾滋病，作为艾滋病毒科学的领先中心，以期为加拿大进步的政策环境 对于有风险的人，并认识到加拿大在全球合作中的领导地位，以解决这种流行病。 2022年艾滋病的具体目标是： 1。加速科学发现，以推动预防HIV和治疗级联的创新， 包括发病机理，传播，疫苗，缓解和功能治愈；长效口头和 可注射的治疗和预防技术，包括预防戒指；集成和差异化 护理模式；以及对健康的结构和经济决定者的分析。 2。加速对治疗指南的更新，尤其是针对低收入和中等收入国家的更新 儿童和艾滋病毒，结核病，病毒性肝炎和covid-19感染的患者。 3。促进从科学，政策和 练习和巩固良好的练习，以进行大流行准备，并进行免疫努力，包括新的 公共和私人利益相关者之间的伙伴关系以及从艾滋病毒反应中的改编中学习 这加速了对Covid-19的反应。 4.实施科学研究的提前核心组成部分，以应对挑战和 在各种流行环境和Covid-19时代的融合机会，包括调查结果 来自社区主导的研究，包括远程医疗在内的服务交付的监测和创新。 5。解决HIV脆弱性并确定钥匙和边缘化的疾病进展 人群，包括新的干预措施和实施科学，以减少污名和歧视， 包括艾滋病毒，同性恋恐惧症，跨性别恐惧症以及种族和种族差异，包括包括 个人/原住民社区中的人以及将行为定罪的影响，包括相同的行为 性关系，非法吸毒和性工作。 6.引起人们注意艾滋病毒反应中的结束差距，例如需要更大投资的领域 在研究和以人为本的服务交付以及社区需求仍然被忽略的地方。 科学计划将由六个曲目组成：跟踪A/基本和翻译研究；跟踪B/临床 研究;跟踪C/流行病学和预防科学；跟踪D/社会和行为研究；轨道e/ 实施研究，经济学，系统和与其他健康和发展领域的协同作用；和 跟踪F/政治研究，法律，政策和人权。虽然会议的科学计划是 由代表不同学科和科学领域的国际轨道委员会开发，交叉 全体会议将涵盖切割方面 领导观点。此外，桥接会话旨在削减至少两个科学 经常使用交互式格式的多学科，多学位对话的轨道。 年轻研究人员，基础科学家和研究人员参与相关领域，例如非 - 通过积极的相关科学和提供，可以加强可传播的疾病 除远程访问选项外，具体的财务支持。会议的关键科学将是 在2022年艾滋病之后，在区域环境中进行了分发和讨论。